The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders.
Scott
Linda M
LM
Campbell
Peter J
PJ
Baxter
E Joanna
EJ
Todd
Tony
T
Stephens
Philip
P
Edkins
Sarah
S
Wooster
Richard
R
Stratton
Michael R
MR
Futreal
P Andrew
PA
Green
Anthony R
AR
D002478:Cells, Cultured; D005820:Genetic Testing; D006801:Humans; D053614:Janus Kinase 2; D009101:Multiple Myeloma / Q000201:enzymology* / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D009196:Myeloproliferative Disorders / Q000201:enzymology* / Q000235:genetics*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D014633:Valine / Q000235:genetics*
D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D014633:Valine